Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

View source ↗

Summary

A recruiting clinical trial evaluating new prognostic biomarkers in patients with liver cirrhosis, focusing on the decompensated stage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: European Foundation for Study of Chronic Liver Failure | Conditions: Liver Cirrhosis, Decompensated Cirrhosis of Liver | Status: RECRUITING